Author

Jean Fontan

OpenAlex ID: A5152395885

PA-366 Prognostic Impact of CDKN2C Mutations in Newly Diagnosed Multiple Myeloma Patients

2026 · Anaïs Schavgoulidze, Luka Pavageau, et al. · Clinical Lymphoma Myeloma & Leukemia

OA-29 First-Year Results of Isatuximab–Iberdomide Maintenance in MRD-Positive Newly Diagnosed Multiple Myeloma Patients Included in the Phase 3 MIDAS Trial

2026 · Aurore Perrot, Jerome Lambert, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 2

Citation count:

H-index:

I10-index: